Bijoy Menon, University of Manitoba

Research

Direct Oral Anti-Coagulants Ischemic Stroke Thrombolysis

Latest funding

Direct Oral Anti-coagulant Associated Stroke Thrombolysis Optimization with Tenecteplase (DOSE)
CIHR · 2025 · Principal investigator
$768,826

All 1 grants and awards

Direct Oral Anti-coagulant Associated Stroke Thrombolysis Optimization with Tenecteplase (DOSE)

Principal investigatorCIHR2025Project Grant

Principal investigators: Singh, Nishita; Menon, Bijoy K

Keywords: Direct Oral Anti-Coagulants; Ischemic Stroke; Thrombolysis

$768,826

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2025

Subject: Prospective PhD student: Direct Oral Anti-Coagulants Dear Professor Menon, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on direct oral anti-coagulants connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Direct Oral Anti-coagulant Associated Stroke Thrombolysis Optimization with Tenecteplase (DOSE)" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]